STATE OF NEW JERSEY VS. C.M. (85-08-0817, HUDSON COUNTY AND STATEWIDE) (RECORD IMPOUNDED) ( 2019 )


Menu:
  •                                       RECORD IMPOUNDED
    NOT FOR PUBLICATION WITHOUT THE
    APPROVAL OF THE APPELLATE DIVISION
    This opinion shall not "constitute precedent or be binding upon any court ." Although it is posted on the
    internet, this opinion is binding only on the parties in the case and its use in other cases is limited. R. 1:36-3.
    SUPERIOR COURT OF NEW JERSEY
    APPELLATE DIVISION
    DOCKET NO. A-2631-17T3
    STATE OF NEW JERSEY,
    Plaintiff-Respondent,
    v.
    C.M.,
    Defendant-Appellant.
    _________________________
    Submitted November 14, 2018 – Decided April 26, 2019
    Before Judges Ostrer and Mayer.
    On appeal from Superior Court of New Jersey, Law
    Division, Hudson County, Indictment No. 85-08-0817.
    Joseph E. Krakora, Public Defender, attorney for
    appellant (Claude Caroline Heffron, Assistant Deputy
    Public Defender, of counsel and on the briefs).
    Esther Suarez, Hudson County Prosecutor, attorney for
    respondent (Erica M. Bertuzzi, Assistant Prosecutor, on
    the brief).
    PER CURIAM
    The trial court denied C.M.'s motion for release from civil commitment
    after a periodic Krol hearing. See State v. Krol, 
    68 N.J. 236
     (1975). Because
    the trial judge did not conduct the requisite fact-finding, apparently failed to
    consider the full record, and shifted the burden to C.M., we remand for
    reconsideration of the entire record under the appropriate legal standard.
    I.
    C.M., who has schizoaffective disorder, major depressive disorder, and
    borderline intellectual functioning, stabbed his mother to death in 1983 while
    under sway of auditory hallucinations.       Though he was on antipsychotic
    medication following a suicide attempt and hospitalization a year earlier, he
    reportedly did not comply with his medication regimen and did not inform his
    mother when he ran out of medication. He was indicted in August 1985, found
    not guilty by reason of insanity two years later, and committed to a state
    psychiatric hospital. He was transferred to Ancora Psychiatric Hospital in June
    1993, where he has remained for the last twenty-five years.
    C.M. has made steady progress at Ancora.          He apparently has not
    attempted violence against himself or others since 1983.1 He has spent a large
    1
    The record reflects that C.M. attempted suicide by swallowing prescription
    medication, bleach, razor blades, and rat poison, but these attempts apparently
    occurred in 1983 or earlier.
    A-2631-17T3
    2
    portion of his time on Level III supervision, the second least restrictive status
    for confined patients. See N.J.A.C. 10:36-1.3 to -1.8 (describing the four levels
    of supervision and procedures for determining the level appropriate for a
    committed patient).
    Generally, C.M.'s understanding of his illness and dangerousness when in
    the throes of psychosis has improved. Earlier in his commitment, C.M. clearly
    lacked insight into his condition – prompting his treatment team to administer
    his medication by injection to avoid his discarding capsules. But since 2007, he
    has evinced, at least at times, a deeper realization of his need for medication.
    He stated in 2007 that he would "likely be dead" had he not been hospitalized .
    In 2008, he was reported "free of assaultive behaviors." His progres s reports
    state that he handles conflicts with peers "quite well" and that he participated
    successfully in several supervised trips out of the hospital.       He has had
    "excellent attendance" at his treatment programs and successfully completed a
    substance abuse program in late 2006.
    Nonetheless, in 2007, staff became concerned that while C.M. "appeared
    to say the right thing about medications," when probed further he lacked real
    insight into his illness. They continued to medicate him in liquid form. In 2009,
    A-2631-17T3
    3
    after staff discovered he had been vomiting one oral medication, they confronted
    and counseled him about complying with his medication.
    Occasionally over the years, C.M. has also demonstrated poor judgment
    by possessing or selling coffee or cigarettes, which are contraband in Ancora.
    He was caught or suspected of contraband infractions four times between 2004
    and 2010.   After his first infraction, he was placed under "periodic visual
    observation," apparently for a few months; in late 2004 he was reinstated to
    Level III status with the approval of the Special Status Patient Review
    Committee (SSPRC), an internal reviewing body at Ancora.          See N.J.A.C.
    10:36-2.2. The SSPRC is comprised of the hospital's Clinical Director or Chief
    of Psychiatry, and directors of psychology, and nursing, rehabilitation, and
    social services. 
    Ibid.
     It makes recommendations based on its own independent
    review of patient records and the treatment team's conclusions. See N.J.A.C.
    10:36-2.3(e).
    In January 2010, C.M. refused a request to transport contraband coffee.
    The SSPRC recommended C.M. for Level IV supervision, permitting him more
    independence and possible passes to visit his sister for a day at a time. See
    N.J.A.C. 10:36-1.8(a) ("Patients at Level of Supervision IV are those who pose
    no or minimal risk of harm to self, others or property and who may be discharged
    A-2631-17T3
    4
    upon finalization of after-care and housing plans.").           The SSPRC also
    recommended that C.M. participate in a twice-weekly "community partial care
    program," and that the trial court authorize his discharge planning subject to the
    approval of two independent psychiatrists. See N.J.A.C. 10:36-1.8(d) ("Most
    often, community-based programs and activities (for example, transitional
    programs, community day programs, community trips), as well as larger group
    activities, shall be part of the individual's overall program at Level IV.").
    However, at his Krol hearing in 2010, the trial judge expressed concern
    about C.M. vomiting his medication and ordered he remain at Ancora. Upon
    finding coffee in C.M.'s possession in May 2010, staff became further concerned
    about the appropriateness of discharge and downgraded him to Level I
    supervision, the most restrictive status, reinstating him to Level III
    approximately a month later. C.M.'s doctor opined that C.M.'s low intellectual
    functioning made "it relatively easy for him to be exploited and used as a mule
    to carry cigarettes and coffee."
    Yet, C.M. improved; his progress notes state that, as of June 2010, he was
    no longer delusional. From mid-2010 through 2012, C.M.'s treatment team
    reported he was increasingly "[i]nsightful into his index offense and the role
    psychiatric illness played." In his own words, C.M. regularly acknowledged his
    A-2631-17T3
    5
    medication kept him from "being suicidal or homicidal"; that his "diagnosis is
    paranoid schizophrenia and I have to be on medication for life"; and that he
    "must take [medication] for the rest of my life, otherwise I might hurt others and
    I don't want that to happen no more. I want to get on with my life." C.M. also
    recognized that his lapse in taking his medication had caused him to kill his
    mother; he described the incident and his state of mind in detail to his treating
    psychiatrist.
    Noting his improvement, C.M.'s treatment team referred him to the
    SSPRC in October 2011 to evaluate his readiness for a group home. The SSPRC
    referred C.M.'s case to the Clinical Assessment Review Panel (CARP), an
    independent central reviewing committee, which approved "discharge planning
    to a 24/7 supervised setting" and recommended "securing evaluations of two
    independent psychiatrists per court order" and seeking the court's permission for
    off-site visits "as part of the discharge planning."
    C.M.'s progress notes from 2012 document both a steady compliance with
    his medication regimen and his psychiatrist's efforts to find him a suitable group
    home. In January 2012, C.M. was "[d]oing very well" and was "[i]nsightful and
    compliant with medications [and] programming." In June 2012, his psychiatrist
    noted he had contacted a group home, and that if the home would accept C.M.,
    A-2631-17T3
    6
    Ancora would begin the discharge process. However, while the group home
    provisionally stated C.M. met its criteria, it had no vacancy. Approaching the
    end of 2012, C.M. continued to acknowledge his need for medication.
    However, in March 2013, C.M.'s treatment team learned from his peer that
    C.M. "has all along been serving as a mule delivering coffee on to the unit." The
    next month, he was caught with coffee and cigarettes, resulting in his placement
    under Level II supervision. While C.M. showed remorse, admitting his actions
    "showed poor judgment," his treatment team was concerned about his
    "compliance under minimal supervision." Though he continued to comply with
    his medication and treatment programs, his team deemed him unready for
    discharge, insisting on a twelve-month period without reportable incident as a
    prerequisite for discharge planning. C.M. again caused concern when staff
    learned in October 2014 that he had been smoking for the previous three weeks
    against his unit's policy, for which he was counseled and placed under closer
    monitoring.
    After meeting with C.M., Ancora's addiction staff informed C.M.'s
    treating psychiatrist that C.M. was attempting to "sabotage[] discharge plans"
    through his infractions because he had become "institutionalized and may
    subconsciously not be able to cope with discharge planning." His progress notes
    A-2631-17T3
    7
    from May to September 2015 conclude with the following observation of C.M.'s
    overall progress:
    The client has remained for the most part without overt
    symptoms of his mental illness. In other words, no
    overt psychosis, denies perceptual disturbance nor
    issues with medication adherence. However he still has
    baseline issues with executive dysfunction . . . [which]
    can manifest themselves in a myriad of ways but in
    particular . . . poor ability to recognize the future
    consequences of action today and the ability to curtail
    impulses.
    As of July 2015, C.M.'s treating psychiatrist was Dr. Allen Y. Masry, who
    submitted a detailed report to the trial court in September 2015, describing
    C.M.'s illness, murder of his mother, progress and setbacks throughout his time
    at Ancora. Dr. Masry reported the treatment team's consensus that C.M. must
    demonstrate twelve incident-free months before beginning discharge planning.
    "When this happens, he would be re-submitted to the SSPRC/CARP and court
    approval sought to begin the process of seeking a group home . . . and consulting
    with two independent psychiatrists . . . ."
    By May 2017, the treatment team again recommended planning for C.M.'s
    discharge to CODI, a group home. Dr. Masry submitted another report to the
    trial court, stating that "for at least the last 12 years no issues with med non
    adherence and since 1983 no issues with suicide attempt." The report explained
    A-2631-17T3
    8
    that CODI had around-the-clock supervision and mandatory curfews, with an
    average of one staff member per every five clients, but that staff could not
    technically keep clients in the home against their will. Dr. Masry assured the
    court, "The staff[] are trained mental health professionals who have extensive
    experience in how to encourage a client to stay," and "should a client not return
    or still choose to leave they would immediately inform authorities."
    Dr. Masry also reported that CODI practices "observed medication
    administration." This meant that staff members administer a client's medication
    for the first thirty days after admission to CODI; thereafter, the patient is
    supplied with a week's worth of medication; a supervisor observes the client
    place the medication in his pillbox and checks the pillbox at week's end.
    However, staff would continue to administer C.M.'s anti-psychotic medication
    intravenously every month. CODI clients attend a day program off premises
    from morning until late afternoon, then return to the home, where they
    participate in group and individual therapy. The report reiterated that C.M. "is
    ready for discharge planning. The entire treatment team believes patient has
    reached maximum benefit with hospitalization." Dr. Masry also reported that
    the SSPRC and CARP had both approved the discharge.
    A-2631-17T3
    9
    In September 2017, C.M.'s new psychiatrist, Dr. Shujaat Nathani – who
    succeeded Dr. Masry – submitted a report recommending discharge to CODI.
    He recounted staff reports from the group home where C.M. had visited on day
    passes during June 2017.      The group home staff reported C.M. "was very
    pleasant," told staff members he "was looking forward to living in the
    community," while noting "he was nervous but willing to give it a chance." They
    reported C.M. met his roommate "and appeared to be very comfortable with him.
    They talked and shared stories about themselves."
    On C.M.'s second visit, the group home staff reported, he seemed more
    relaxed and socialized with residents at the home. He appeared "fully oriented,"
    showed "logical thinking and clear and appropriate thought content" and
    "described willingness to adhere to medication orders and program guidelines."
    C.M. also communicated openly about his experience in Ancora "and the crime
    he committed to be hospitalized." Dr. Nathani followed up with a second report
    in December 2017, which reproduced Dr. Masry's May 2017 report nearly
    verbatim and recommended discharge to CODI. Neither of Dr. Nathani's reports
    included C.M.'s clinical history or any details of his past lapses and future risks
    for non-compliance with medication.
    A-2631-17T3
    10
    The sole witness at the Krol hearing in December 2017, Dr. Nathani
    testified about C.M.'s progress, the conditions of CODI, and C.M.'s past
    infractions. However, while he stated he had reviewed Dr. Masry's reports, Dr.
    Nathani could not identify the crime for which C.M. had been initially
    committed. Though the State's counsel pressed him, he could not recall – until
    counsel reminded him – that C.M. had murdered his own mother.
    Although the State had called Dr. Nathani as a witness, at the close of his
    testimony, the assistant prosecutor renewed a request that the court appoint an
    independent psychiatrist to examine C.M. The court did not rule on the renewed
    request. In summation, the prosecutor challenged Dr. Nathani's opinion, and
    objected to C.M.'s discharge, contending the community facility was "not secure
    enough to ensure the safety of the community" and C.M. lacked prior experience
    in his own medication management.
    C.M.'s attorney urged the court to approve C.M.'s discharge. Counsel
    argued, based on the opinions of both Dr. Masry and Dr. Nathani, that C.M. was
    no longer a danger to himself or others, noting the absence of violent conduct in
    recent years, and the persistence in his system of his medication even if he
    temporarily stopped taking it.
    A-2631-17T3
    11
    In his oral decision, the trial judge announced that he found Dr. Nathani's
    testimony incredible and unhelpful, since the doctor could not recall C.M.'s
    initial offense and the court could find "no basis for . . . his opinion that's been
    put into the record."2 The trial judge therefore concluded that "the status quo
    will remain in effect." The court issued a written order in January 2018, stating
    that it found C.M. remained a danger to himself and others and requiring his
    continued hospitalization, while ordering "discharge planning at the
    recommendation of Dr. Nathani and the team, which shall include specific
    details as to placement, therapy, and medications."
    II.
    Aside from questions of law, which we review de novo, Manalapan
    Realty, L.P. v. Twp. Comm. of Manalapan, 
    140 N.J. 366
    , 378 (1995), our scope
    of review of a commitment or recommitment order is "extremely narrow." State
    v. Fields, 
    77 N.J. 282
    , 311 (1978). We accord "the utmost deference . . . [to] the
    reviewing judge's determination as to the appropriate accommodation of the
    competing interests of individual liberty and societal safety in the particular
    case." 
    Ibid.
     We have the "responsibility to canvass the record inclusive of the
    2
    Though the trial court did not elaborate on this statement, it apparently meant
    to highlight the lack of detail in Dr. Nathani's written report, which omitted
    C.M.'s clinical history and risks.
    A-2631-17T3
    12
    expert testimony to determine whether the findings made by the trial judge were
    clearly erroneous." In re J.M.B., 
    395 N.J. Super. 69
    , 90 (App. Div.), aff'd, 
    197 N.J. 563
     (2009). We will modify a commitment order "only if the record reveals
    a clear mistake." In re D.C., 
    146 N.J. 31
    , 58 (1996).
    Nonetheless, we will overturn a ruling that is "so wholly insupportable as
    to result in a denial of justice," Greenfield v. Dusseault, 
    60 N.J. Super. 436
    , 444
    (App. Div.), aff'd o.b. 
    33 N.J. 78
     (1960), or is based on an "obvious overlooking
    or underevaluation of crucial evidence," State v. Johnson, 
    42 N.J. 146
    , 162
    (1964). We will also reverse where the trial court fails to explain the reasons
    for its decision. See Curtis v. Finnean, 
    83 N.J. 563
    , 569-70 (1980); R. 1:7-4(a).
    The State may commit individuals found not guilty by reason of insanity
    (NGI) so long as they pose a danger to themselves or others. In re W.K., 
    159 N.J. 1
    , 2 (1999). Commitment aims not to penalize but "to protect society
    against individuals who, through no culpable fault of their own, pose a threat to
    public safety." Krol, 
    68 N.J. at 246
    . A trial court determining the propriety of
    commitment must evaluate whether the NGI acquittee poses "a substantial risk
    of dangerous conduct within the reasonably foreseeable future," considering
    both the likelihood and seriousness of dangerous conduct.             
    Id. at 260
    .
    Dangerousness to oneself or others includes risk of death, serious bodily injury,
    A-2631-17T3
    13
    or serious property damage. N.J.S.A. 30:4-27.2(h), (i). The State does not
    satisfy its burden by raising the mere possibility that an individual might become
    dangerous at some future point. Krol, 
    68 N.J. at 260
    .
    Once committed, NGI acquittees have a right to periodic reviews – known
    as Krol hearings – generally "under the same standards as those applied to civil
    commitments" to determine the ongoing need to commit. In re M.M., 
    377 N.J. Super. 71
    , 76 (App. Div. 2005), aff'd o.b., 
    186 N.J. 430
     (2006). "[T]he [S]tate
    must bear the burden of proving the necessity of recommitment, just as it bears
    the burden of proving the necessity for commitment." Fields, 
    77 N.J. at 300
    (quoting Fasulo v. Arafeh, 
    378 A.2d 553
    , 557 (Conn. 1977)). However, one
    important exception is "that the burden of establishing the need for continued
    commitment is by a preponderance of the evidence, whereas in a civil
    commitment proceeding it is by clear and convincing evidence." W.K., 
    159 N.J. at 4
    ; N.J.S.A. 2C:4-8(b)(3) (establishing preponderance-of-the-evidence
    standard of proof).
    The regularity of Krol hearings is designed to facilitate continuous
    reevaluation of the status quo. Matter of Newsome, 
    176 N.J. Super. 511
    , 516
    (App. Div. 1980). A trial court must therefore draw factual conclusions about a
    committee's current degree of dangerousness, based on "history, recent behavior
    A-2631-17T3
    14
    and any recent act, threat or serious psychiatric deterioration." N.J.S.A. 30:4-
    27.2(h). While the court may "give substantial weight" to past crimes and their
    "relationship to [a committee's] present mental condition," the court's ultimate
    task is "prediction of [the committee]'s future conduct rather than mere
    characterization of his [or her] past conduct." Krol, 
    68 N.J. at 260-61
    . A
    committee's "criminal act, while certainly sufficient to give probable cause to
    inquire into whether he is dangerous, does not, in and of itself, warrant the
    inference that he presently poses a significant threat of harm, either to himself
    or to others." 
    Id. at 247
    .
    A trial court determining dangerousness should consider expert opinion.
    
    Id. at 261
    . However, it should not entirely defer to psychiatric assessments,
    because the issue of dangerousness, as a factor in the "delicate balancing of
    society's interest in protection from harmful conduct against the individual's
    interest in personal liberty and autonomy," is ultimately legal, not medical. 
    Ibid.
    Though "[d]oubts must be resolved in favor of protecting the public, . . . the
    court should not, by its order, infringe upon defendant's liberty or autonomy any
    more than appears reasonably necessary to accomplish this goal." Ibid.; see also
    State v. Ortiz, 
    193 N.J. 278
    , 292 (2008).
    A-2631-17T3
    15
    Applying these principles to the facts before us, we conclude that the trial
    court's factual findings – which relate only to Dr. Nathani's credibility but not
    to C.M.'s condition – are insufficient to support the recommitment order. Also,
    the court erroneously shifted the burden of proof to C.M., and it failed to
    consider the full record.    Although the trial court's order stated that C.M.
    "continues to be a danger to himself and to society, for the reasons stated on the
    record," the record reveals no such reasons. The court made its single factual
    finding immediately following Dr. Nathani's testimony; however, it did not
    reference C.M.'s dangerousness, only the court's impression of Dr. Nathani's
    testimony:
    It really doesn't matter [whether Dr. Nathani is
    qualified as an expert witness], because . . . I'm familiar
    with Dr. Masry. Over the several times he was here, I
    caused him and required him to make more detailed
    reports, and apparently, he didn't pass that information
    onto his successor doctor, because even though . . . Dr.
    Nathani may be an expert, I find his opinion to be a net
    opinion. There's been no basis for . . . his opinion that's
    been put into the record. And frankly, I'm shocked that
    he didn't know the reason the defendant was there for
    murder. I don't believe that he remembered it at all. I
    don't think he even knew it, frankly, based on the
    manner in which he testified. . . . I find his opinion to
    be a net opinion, and therefore, not convincing . . . to
    this Court in any degree whatsoever. Therefore, the
    status quo will remain in effect.
    [(Emphasis added).]
    A-2631-17T3
    16
    The trial judge based his decision on the following premises: (a) Dr.
    Nathani's testimony was not credible, in part because he did not know C.M. was
    originally committed after murdering his own mother; (b) Dr. Nathani's opinion
    was unavailing because it was "net," meaning it lacked a supporting basis in the
    record; and (c) therefore, the status quo must remain in effect.
    While we defer to the trial court's appraisal of Dr. Nathani's credibility,
    its limited finding regarding the expert's testimony does not support the
    conclusion that C.M. remains dangerous. The court neither expressly addressed
    whether C.M. remains dangerous nor recited facts pertinent to that issue.
    Conceivably, the court could have based a dangerousness finding on evidence
    suggesting that C.M. would not comply with his medication, but the court did
    not. Instead, the trial court stated only its conclusions regarding Dr. Nathani's
    testimony, without addressing C.M.'s dangerousness, the essential issue.
    Therefore, the findings the trial court announced did not support finding C.M.
    dangerous.
    In addition, the trial court erred in presuming the status quo must continue
    absent evidence to the contrary. Instead of requiring the State to meet its burden
    of showing by a preponderance that C.M. is still so dangerous as to require
    A-2631-17T3
    17
    confinement, the trial court, by implication and in effect, burdened C.M. with
    the obligation to prove commitment is no longer warranted.
    Finally, the trial court apparently failed to consider the full record,
    particularly reports by Dr. Masry recommending C.M. be considered for
    discharge. Dr. Masry's reports did not suffer from the shortcomings the court
    identified in Dr. Nathani's report and testimony. Dr. Masry set forth the basis
    for his opinions, and he was well aware that C.M. had murdered his mother. Dr.
    Masry's first report, from 2015, set forth C.M.'s entire history at length, detailing
    both progress and setbacks and accounting for C.M.'s murder of his mother and
    past attempts at self-harm. Dr. Masry concluded his assessment by stating that
    C.M. still suffers from mental illness and borderline intellectual functioning,
    and he remains at risk of violence if not medicated and of being exploited.
    Noting that C.M. has "adequate insight" into his illness, "fair insight" into his
    need for medication, and "poor judgment" about possessing contraband, Dr.
    Masry recommended a year-long trial period before discharge planning.
    Dr. Masry's second report, from 2017, did not rehash C.M.'s history.
    Instead, it began by noting that C.M.'s last suicide attempt was in 1983; his last
    statement about self-harm was in 1993; and his last non-compliance with his
    medication regimen was in 2004, "a one-time incident."             The report then
    A-2631-17T3
    18
    described the CODI group home requested for C.M., explaining its policies on
    supervision, dispensing medication, and other issues. Dr. Masry stated that he,
    C.M.'s treatment team, the SSPRC and CARP all agreed that C.M. "is ready for
    discharge planning." In the meantime, Dr. Masry recommended, among other
    steps, allowing C.M. brief supervised visits followed by random drug screening,
    and that until court approval, C.M. should continue hospitalization and regular
    Krol hearings. In sum, avoiding the problems in Dr. Nathani's opinion, Dr.
    Masry recommended a measured approach towards discharging C.M. to the
    group home after concluding he had received all that Ancora could provide him.
    The court's failure to address Dr. Masry's reports also warrants reversal.
    Reversed and remanded. We do not retain jurisdiction.
    A-2631-17T3
    19